MSL
NVRO

Mackay Shields LLC’s NEVRO CORP. NVRO Stock Holding History

Mackay Shields LLC’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,700
Closed -$655K – 1371
2021
Q1 		$655K Sell
4,700
-1,600
-25% -$261K ﹤0.01% 1129
2020
Q4 		$1.09M Sell
6,300
-1,600
-20% -$259K 0.01% 1060
2020
Q3 		$1.1M Buy
7,900
+4,100
+108% +$548K 0.01% 1002
2020
Q2 		$454K Sell
3,800
-11,000
-74% -$1.3M ﹤0.01% 1220
2020
Q1 		$1.48M Buy
+14,800
New +$1.78M 0.01% 797

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mackay Shields LLC's NVRO Position: Q2 2021 in Review

Mackay Shields LLC sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 4,700 shares — an estimated $655K sold.

Mackay Shields LLC first reported a position in NVRO in Q1 2020 and held it in 5 quarters. The position peaked at $1.48M in Q1 2020. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

  • Mackay Shields LLC reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 4,700 NEVRO CORP. shares in Q2 2021, an estimated $655K.
  • Mackay Shields LLC first reported a position in NEVRO CORP. in Q1 2020 and held it in 5 quarters.
  • Mackay Shields LLC's NEVRO CORP. position peaked at $1.48M in Q1 2020.
  • 207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.